New combo attack on aggressive breast cancer before surgery
NCT ID NCT06682195
Summary
This study is testing whether adding an immunotherapy drug called toripalimab to standard chemotherapy before surgery can be more effective for treating triple-negative breast cancer. It will involve about 35 women with early-stage disease to see if this combination can completely eliminate cancer cells from the breast and lymph nodes. Researchers will also track side effects and how long patients remain cancer-free after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TNBC, TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Harbin Medical University Cancer Hospital
NOT_YET_RECRUITINGHarbin, China
Contact
-
Jinhua Municipal Central Hospital
RECRUITINGJinhua, China
Contact
-
Nanchang People's Hospital
NOT_YET_RECRUITINGNanchang, Jiangxi, China
Contact
-
Nantong First People's Hospital
RECRUITINGNantong, China
Contact
-
Shanxi Provincial Cancer Hospital
NOT_YET_RECRUITINGShanxi, China
Contact
-
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
RECRUITINGHangzhou, China
Contact
-
The First Affiliated Hospital of Anhui Medical University
RECRUITINGHefei, China
Contact
-
The First Affiliated Hospital of Zhejiang University
RECRUITINGHangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, China
Contact
-
The Second Affiliated Hospital of Xi'an Jiaotong University
NOT_YET_RECRUITINGXi'an, China
Contact
-
Xinjiang Medical University Affiliated Cancer Hospital
NOT_YET_RECRUITINGXinjiang, China
Contact
-
Zhejiang Cancer Hospital
RECRUITINGHangzhou, China
Contact
-
Zhongshan Hospital, Fudan University
RECRUITINGShanghai, China
Contact
Conditions
Explore the condition pages connected to this study.